Trials / Sponsors / Baohui Han
Baohui Han
Academic / Other · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC Non-Small Cell Lung Cancer | — | 2025-03-01 |
| Recruiting | Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics Lung Cancer (Diagnosis), Fragmentomics | — | 2024-08-21 |
| Not Yet Recruiting | Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-trea Extensive-stage Small-cell Lung Cancer | Phase 1 / Phase 2 | 2024-04-01 |
| Unknown | Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns Lung Cancer | Phase 2 | 2022-01-14 |
| Completed | Combination of Chemotherapy and Gefitinib as First-line Treatment Non-Small-Cell Lung Cancer | N/A | 2014-05-01 |
| Completed | Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation. Non Small Cell Lung Cancer | Phase 2 | 2011-03-02 |